Table:
begin	end	state
1	29	cytoplasmic
30	52	transmembrane
53	64	non-cytoplasmic
65	84	transmembrane
85	94	cytoplasmic
95	114	transmembrane
115	120	non-cytoplasmic
121	142	transmembrane
143	152	cytoplasmic
153	174	transmembrane
175	180	non-cytoplasmic
181	204	transmembrane
205	253	cytoplasmic
254	282	transmembrane
283	300	non-cytoplasmic
301	321	transmembrane
322	328	cytoplasmic
329	346	transmembrane
347	351	non-cytoplasmic
352	370	transmembrane
371	389	cytoplasmic
390	414	transmembrane
415	420	non-cytoplasmic
421	442	transmembrane
443	448	cytoplasmic

Input:
>Pf1N1B4_3231 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_3231
MNQPQSAVGNCLDVQSFINTQPISRYQWRVVILCFLIVFLDGLDTAAMGFIAPALSQDWG
IDRASLGPVMSAALIGMVFGALGSGPLADRFGRKVVLVGAVLVFGAFSLASAYSTNVDQL
LVLRFLTGLGLGAGMPNATTLLSEYTPERKKSLLVTSMFCGFNLGMAGGGFISAKLIPAF
GWHSLLMIGGVLPLILAVVLLFWLPESARYLVVRNRGTDKVRKTLAPIDPAMVAQASSFS
VPEQKTVKARNVFAVIFSGTYSTGTLLLWLTYFMGLVIVYLLTSWLPTLMRDSGASMEQA
AFIGALFQFGGVLSAVGVGWAMDRFNPHKVIGIFYLFAGVFAYAVGQSLGSITLLATLVL
VAGMCVNGAQSAMPSLAARFYPTQGRATGVSWMLGIGRFGAILGAWMGATLLGLGWNFEQ
VLTALVIPAALATTAVVIKGMVSHADAT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server